Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-032224
Filing Date
2013-06-14
Accepted
2013-06-14 16:14:22
Documents
1
Period of Report
2013-06-12

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c554074_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c554074_4x0.xml 4 6603
  Complete submission text file 0001209191-13-032224.txt   8051
Mailing Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address
BRISTOW MICHAEL R (Reporting) CIK: 0001266125 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 13914425